A Case of Ovarian Steroid Cell Tumor, Not Otherwise Spe-cified, Treated with Surgery and Gonadotropin Releasing Hormone Agonist
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Steroid cell tumors account for less than 0.1% of all ovarian tumors. There are three steroid cell tumor subtypes: steroid cell tumor not otherwise specified (NOS), stromal luteoma and Leydig cell tumor. Steroid cell tumor, NOS, is the most common type and has malignant potential. This report describes a case of an ovarian steroid cell tumor, NOS. A 35-year-old woman visited hospital with the complaint of metrorrhagia. Physical examination revealed increased pubic hair. Transvaginal ultrasound indentified a 4.9 × 3.4 cm, well-circumscribed and solid left ovarian tumor. After laparoscopic left oophorectomy, the tumor was revealed as an ovarian steroid cell tumor, NOS. During the laparoscopic surgery, tumor ruptured. Complete surgical staging was performed and no evidence of metastasis was found. Gonadotropin releasing hormone agonist was administered monthly for 6 months. The patient has had no evidence of recurrence for 43 months. (J Menopausal Med 2014;20:39-42)
Abstract
Steroid cell tumors account for less than 0.1% of all ovarian tumors. There are three steroid cell tumor subtypes: steroid cell tumor not otherwise specified (NOS), stromal luteoma and Leydig cell tumor. Steroid cell tumor, NOS, is the most common type and has malignant potential. This report describes a case of an ovarian steroid cell tumor, NOS. A 35-year-old woman visited hospital with the complaint of metrorrhagia. Physical examination revealed increased pubic hair. Transvaginal ultrasound indentified a 4.9 × 3.4 cm, well-circumscribed and solid left ovarian tumor. After laparoscopic left oophorectomy, the tumor was revealed as an ovarian steroid cell tumor, NOS. During the laparoscopic surgery, tumor ruptured. Complete surgical staging was performed and no evidence of metastasis was found. Gonadotropin releasing hormone agonist was administered monthly for 6 months. The patient has had no evidence of recurrence for 43 months. (J Menopausal Med 2014;20:39-42)
참고문헌 (14)
- Reedy MB, "Ovarian steroid cell tumors, not otherwise specified:a case report and literature review", Gynecol Oncol, 75, pp.293~297 (1999)
- Wang PH, "Use of a long-acting gonadotropin-releasing hormone agonist for treatment of steroid cell tumors of the ovary", Fertil Steril, 69, pp.353~355 (1998)
- Wang PH, "Steroid cell tumors of the ovary: clinical, ultrasonic, and MRI diagnosis-a case report", Radiol, 26, pp.269~273 (1998)
- Luk WT, "Lipid cell tumor of the ovary associated with endometrial adenocarcinoma-a case report", Changgeng Yi Xue Za Zhi, 12, pp.244~248 (1989)
- Hayes MC, "Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63cases", Am J Surg Pathol, 11, pp.835~845 (1987)
- Law KS, "Fertility-sparing treatment of a primary retroperitoneal mucinous cystadenocarcinoma", BJOG, 113, pp.612~614 (2006)
- 송민경, "다량의 복수를 동반한 비특이 스테로이드세포종양 1예", Obstetrics & Gynecology Science, 46(12), pp.36~36 (2003), 대한산부인과학회
- 문기숙, "난소의 지방 세포종 1예", Obstetrics & Gynecology Science, 47(3), pp.585~588 (2004), 대한산부인과학회
- 오자랑, "복강경으로 처치한 무증상의 비특이 스테로이드세포 종양 1예", Obstetrics & Gynecology Science, 49(4), pp.933~938 (2006), 대한산부인과학회
- 김영태, "An Ovarian Steroid Cell Tumor Causing Virilization and Massive Ascites", Yonsei Medical Journal, 48(1), pp.142~146 (2007), 연세대학교의과대학
- 김흥곤, "고혈압과 비만 및 복수가 동반되면서 CA 125가 상승한 난소의 비특이 스테로이드세포종양 1예", Obstetrics & Gynecology Science, 51(10), pp.1164~1169 (2008), 대한산부인과학회
- 박준식, "폐경 여성에게서 발생한 그물 낭종 1예", 대한폐경학회지, 18(1), pp.67~69 (2012), 대한폐경학회[DOI]
- Pascale MM, "Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours", Clin Endocrinol, 41, pp.571~576 (1994)
- Imai A, "Direct action of gonadotropinreleasing hormone (LH-RH) analogue on ovary: an alternative acting mechanism of buserelin", Arch Gynecol Obstet, 248, pp.117~121 (1991)